Similar articles

• Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT.

  Holme I, Helgeland A, Hjermann I, Leren P, Lund-Larsen PG. Holme I, et al. JAMA. 1984 Mar 9;251(10):1298-9. JAMA. 1984. PMID: 6366258 Clinical Trial.
• The Multiple Risk Factor Intervention Trial (MRFIT). A return to a landmark trial.

  Gotto AM Jr. Gotto AM Jr. JAMA. 1997 Feb 19;277(7):595-7. JAMA. 1997. PMID: 9032169 No abstract available.
• Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial.

  Rautaharju PM, Neaton JD. Rautaharju PM, et al. Clin Invest Med. 1987 Nov;10(6):606-15. Clin Invest Med. 1987. PMID: 3326700 Review.
• The multiple risk factor intervention trial (MRFIT): implications for nurses.

  Ackerman AM, Froman D, Becker DM. Ackerman AM, et al. Prog Cardiovasc Nurs. 1987 Jul-Sep;2(3):92-9. Prog Cardiovasc Nurs. 1987. PMID: 3313379 Clinical Trial. No abstract available.
• [Coronary risk factors: facts and open questions].

  Valagussa F. Valagussa F. G Ital Cardiol. 1991 May;21(5):563-79. G Ital Cardiol. 1991. PMID: 1936761 Review. Italian. No abstract available.